VG Life Sciences Secures $2,235,000 New Round

  • Feed Type
  • Date
    10/4/2013
  • Company Name
    VG Life Sciences
  • Mailing Address
    121 Gray Ave. Santa Barbara, CA 93101
  • Company Description
    VG Life Sciences Inc. is a drug discovery and development company researching two core technologies: Targeted Peptides and Metabolic Disruption.The Company is researching the use of these technologies in the treatment of cancer, infectious disease, and inflammation.
  • Website
    http://www.vglifesciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,235,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This new funding will enable VG Life Sciences to begin and complete many key milestones outlined in the Company’s July Investor Letter and meet short term capital needs.
  • M&A Terms
  • Venture Investor
    MedBridge Venture Fund

By posting a comment, you agree to our terms and conditions.